ACN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Accenture PLC (ACN) is currently not an optimal buy for a beginner investor with a long-term strategy. While the company has strong fundamentals and positive long-term prospects, the recent price decline, bearish technical indicators, and mixed sentiment from analysts suggest waiting for stabilization before entering a position.
The stock is currently in a bearish trend. The MACD histogram is negative and expanding (-4.378), RSI is at 20.84, indicating oversold conditions, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 221.399, with resistance at 242.023. The stock has broken below its pivot level, signaling further downside risk.
Accenture Federal Services secured a 4.5-year contract to support the U.S. Department of Veterans Affairs' Electronic Health Record Modernization program, which could drive long-term revenue growth.
Analysts like Berenberg and Truist have reiterated Buy ratings with price targets above $300, citing Accenture's strong positioning in AI-led enterprise transformation.
Recent price decline of -3.64% in the regular market and -0.68% post-market, with the broader market (S&P
also down -1.54%.
Weakness in IT Services/BPO stocks due to Anthropic's new plug-ins and Gartner's weak earnings release.
Mixed financial performance in Q1 2026, with net income and EPS declining YoY despite revenue growth.
In Q1 2026, Accenture's revenue increased by 5.95% YoY to $18.74 billion, but net income dropped by -2.95% YoY to $2.21 billion, and EPS fell by -1.39% YoY to 3.54. Gross margin improved slightly to 33.07%, up 0.46% YoY.
Analysts have mixed views. Berenberg and Truist have Buy ratings with price targets above $300, citing Accenture's strong positioning in AI and enterprise transformation. However, recent weakness in IT Services/BPO stocks has caused concern. Morgan Stanley upgraded the industry view to In-Line, expecting modest growth in consulting and services spending over the next 12-18 months.
